resisttbSep 31 min readCHMP Grants Positive Opinion for Expanded Use of Otsuka’s Deltyba® (delamanid) in Children and AdoleUpdated: Oct 4The European Medicines Agency has updated its stance on Deltyba—with implications for children with DR-TB.Read about it here.1 view
The European Medicines Agency has updated its stance on Deltyba—with implications for children with DR-TB.Read about it here.
View the Slides from Our Most Recent Webinar (Click to View)Global Access to TB Drug Susceptibility Testing, 2020
Public Investment in Bedaquiline Up to Five-Fold That of Johnson & JohnsonThe driving contributor to safer, all-oral TB regimens may not be who you think, with more credit due to the government than private enterprises. Read about it here.